EN | UA
EN | UA

Help Support

Back

Efficacy of vonoprazan and amoxicillin dual therapy in H. pylori patients

H._pylori_elimination H._pylori_elimination
H._pylori_elimination H._pylori_elimination

This randomized controlled trial aimed to investigate effectiveness of vonoprazan based dual therapy vs proton pump inhibitor (PPI) based therapy for elimination of Helicobacter pylori (H. pylori) infection.

See All

Key take away

Vonoprazan based dual treatment offers an acceptable H. pylori elimination rate with reduced adverse events.

Background

This randomized controlled trial aimed to investigate effectiveness of vonoprazan based dual therapy vs proton pump inhibitor (PPI) based therapy for elimination of Helicobacter pylori (H. pylori) infection.

Method

The study included 192 H. pylori-infected people (age 18-75 years) and randomized them into (i) Group-A (n=96): Received 1 gm amoxicillin capsule; 500 mg clarithromycin tablet; 20 mg omeprazole capsule twice daily for two weeks, (ii) Group-B (n=96): Received 1 gm amoxicillin capsule; 20 mg vonoprazan tablet twice daily for two weeks.

Confirmation of H. pylori elimination was done by stool H. pylori antigen test four weeks following therapy completion. The assessment was carried out on 87 people in Group A and 92 people in Group B.

Result

The percentage of people with negative H. pylori results after treatment, is shown in Table 1:

Substantially greater frequencies of adverse events were noted in Group A in comparison with Group B in bloating and nausea/vomiting.

Conclusion

Compared to conventional PPI based triple therapy, the vonoprazan based dual therapy was more likely to eliminate H. pylori. Thus, vonoprazan-amoxicillin dual therapy appears to be a promising new first-line therapy for H. pylori infection.

Source:

Pakistan Journal of Medical Sciences

Article:

Comparison of Vonoprazan and Amoxicillin Dual Therapy with Standard Triple Therapy with Proton Pump Inhibitor for Helicobacter Pylori eradication: A Randomized Control Trial

Authors:

Bader Faiyaz Zuberi et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: